One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment.
Tseng TC, Choi J, Nguyen MH, Peng CY, Siakavellas S, Papatheodoridis G, Wang CC, Lim YS, Lai HC, Trinh HN, Wong C, Wong C, Zhang J, Li J, Kao JH.
Tseng TC, et al. Among authors: choi j.
Hepatol Int. 2021 Feb;15(1):105-113. doi: 10.1007/s12072-020-10124-z. Epub 2021 Feb 5.
Hepatol Int. 2021.
PMID: 33547557
Free PMC article.